Crystagen is a crucial bio-regulatory peptide primarily designed to enhance the body’s immune regulatory capacity. Systematic exploration of thymus function and its secretory substances led to its synthesis through highly deliberate design.
Since discovery, multi-level, multi-target biological regulatory capabilities have been demonstrated for Crystagen. The core efficacy lies in significantly and precisely improving various aspects of immune system function.
Immunomodulatory power specifically comes from positive regulation of specific T lymphocyte subsets – helper Th cells being the prime example, sammen med cytotoxic T cells; stimulation of their proliferation, aktivering, and subsequent secretion of effector molecules is central to this process.
B-cell related activation and humoral immunity is also modulated, synergistically completing the immune response.
Mimicking endogenous immune signaling molecules itself is one of Crystagen’s key mechanisms; ligand-receptor type interactions on the surface of immune cells initiate intracellular pathways.
Some clinical studies have reported a direct anti-inflammatory effect, reducing the various forms of immune stress damage the body incurs.
Normalization of microenvironmental states is a desired end point.
Potent immunomodulation (current and future) is what Crystagen aims to achieve.
Sekvens
Glu-Asp-Pro
CAS nummer
/
Molekylær formel
C14H21N3O8
Molekylvægt
359.335
Research Of Crystagen Peptide
1.Regulating lymfocytter
Direct action on cellular immune responses is Crystagen’s primary focus.
Faster, more effective activation and the full range of proper differentiation into functional effector T cells upon antigen encounter are all part of this process.
2.Modulering af (programmable) immune signaling
Som nævnt ovenfor, all of the previous points lead to a programmed activation of the immune system.
Immune cells can and will change their state in response to Crystagen.
3.Cell Protection and Homeostatic Maintenance
Crystalgen mitigates oxidative stress damage specifically to immune cells.
Upregulation of various intracellular antioxidants (glutathione være et godt eksempel) is the primary mechanism of action in this process.
Samtidig, inhibition of the mitochondrial apoptosis vej – through regulated expression of the Bcl-2 family proteiner – is observed; reduced apoptosis of these cells directly leads to longer survival times and subsequent functional endurance.
Maintaining a stable microenvironment within the body is another key property Crystalgen exhibits.
Regulating (and restoring) the proper proportion of different immune cell subsets is how these more global immune functions are re-established: surveillance, active defense, and clearance functions.
Kræft adjuvant therapy is one of the more desirable end applications of this line of immune protection.
COA
HPLC
MS
